BATON ROUGE, La., Sept. 26 Albemarle Corporation(NYSE: ALB), a global supplier of the active pharmaceutical ingredientIbuprofen, will increase the price of its Ibuprofen 40 micron and Ibuprofen 70micron products by 12 percent, and its Ibuprofen 20 micron product by 20percent, worldwide, effective October 15, 2007, or as contracts allow.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )
"Albemarle proudly stands behind its quality record, which is supportedthrough decades of outstanding FDA inspection performance at our plant inOrangeburg, South Carolina," said Brian Carter, Global Business Manager,Pharmaceutical Actives. "This price increase will allow us to continue tosupply the industry with a consistent, reliable supply of what we believe isthe highest quality Ibuprofen available on the market today."
Albemarle Corporation, headquartered in Richmond, Virginia, is a leadingglobal developer, manufacturer and marketer of highly engineered specialtychemicals for petroleum and petrochemical processing; transportation andindustrial products; consumer electronics; pharmaceuticals; agriculturalproducts; and construction and packaging materials. The Company operates inthree business segments, Polymer Additives, Catalysts and Fine Chemicals, andserves customers in approximately 100 countries. For more information aboutAlbemarle, please visit www.albemarle.com.
ALBEMARLE is a registered trademark of Albemarle Corporation.
"Safe Harbor" Statement under the Private Securities Litigation Reform Actof 1995: Statements in this press release regarding Albemarle Corporation'sbusiness which are not historical facts are "forward-looking statements" thatinvolve risks and uncertainties. For a discussion of such risks anduncertainties, which could cause actual results to differ from those containedin the forward-looking statements, see "Risk Factors" in the Company's AnnualReport on Form 10-K.
SOURCE Albemarle Corporation